Trial Profile
A retrospective, observational study analysing safety and efficacy of deferasirox treatment for iron overload in patients with myelodysplastic syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2016
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Iron overload; Myelodysplastic syndromes
- Focus Therapeutic Use
- 30 Nov 2016 New trial record